Aluminium nicotinate
Chemical compound
- C10AD04 (WHO)
- aluminium tris(pyridine-3-carboxylate)
- 1976-28-9
- 16098
- 19954489 Y
- BDI80PUH9N
- DTXSID60173441
- Interactive image
- [Al+3].OC(=O)c1cccnc1
InChI
- InChI=1S/C6H5NO2.Al/c8-6(9)5-2-1-3-7-4-5;/h1-4H,(H,8,9);/q;+3 Y
- Key:RIROQZQPXBZPCI-UHFFFAOYSA-N Y
Aluminium nicotinate is a niacin derivative used as a hypolipidemic agent.
References
- ^ Budavari S, O'Neil M, Smith A, Heckelman P, Obenchain J (1996). The Merck Index: an Encyclopedia of Chemicals, Drugs, and Biologicals (12th ed.). Whitehouse Station, NJ: Merck. p. 364. ISBN 978-0-911910-12-4.
- v
- t
- e
Lipid-lowering agents (C10)
Cholesterol absorption inhibitors, NPC1L1 |
|
---|---|
Bile acid sequestrants/resins (LDL) |
Statins (HMG-CoA reductase, LDL) | |
---|---|
Niacin and derivatives (HDL and LDL) |
|
MTTP inhibitors (VLDL) | |
ATP citrate lyase inhibitors (LDL) | |
Thyromimetics (VLDL) |
PPAR agonists (LDL) |
| ||||
---|---|---|---|---|---|
CETP inhibitors (HDL) | |||||
PCSK9 inhibitors (LDL) | |||||
ANGPTL3 inhibitors (LDL/HDL) |
- #WHO-EM
- ‡Withdrawn from market
- Clinical trials:
- †Phase III
- §Never to phase III
This drug article relating to the cardiovascular system is a stub. You can help Wikipedia by expanding it. |
- v
- t
- e